OGL Medical - Your Healthcare Specialist

SINOPHARM COVID-19 VACCINATION

What you need to know about Sinopharm vaccine

The sixth vaccine to be authorised by the World Health Organisation (WHO) for its emergency listing, receiving WHO validation for safety, efficacy and quality. Developed by the Beijing Bio-Institute of Biological Products Co Ltd, a subsidiary of China National Biotec Group (CNBG), Sinopharm is an inactivated vaccine called SARS-CoV-2 Vaccine.

OGL Medical Group has received approval under the SAR to provide Sinopharm COVID-19 vaccines in Singapore. Registration for interest in the Sinopharm vaccine is now available.

Thank you for your interest in the Sinopharm Covid-19 Vaccine.

The demand for the vaccine exceeds our available stock and we regret to inform you that our first batch of vaccines has been fully committed as of 31 August 2021. OGL Medical Group is working hard to procure a steady supply of vaccines from our manufacturing partner and will be releasing details once we have confirmation on the delivery of the next batch.

Thank you for your patience and we look forward to updating you when we have further information. Please register your interest in the vaccine below for updates on the availability of the vaccine.

What’s different about the Sinopharm vaccine?

It uses inactivated virus to fight against COVID-19

Sinopharm uses a traditional and widely known method of inactivated virus to protect against COVID-19.

The virus is inactivated through chemical treatment

Beta-propiolactone is the chemical that binds to the SARS-CoV-2 virus’ genetic material and inactivates it, preventing it from replicating and causing COVID-19.

It is stored at normal fridge temperatures

Like the traditional flu vaccination, Sinopharm can be stored at normal refrigerator temperatures.

Who is eligible for taking Sinopharm?

Individuals aged 18 years and older, with no history of anaphylaxis.

Individuals with a history of anaphylaxis or any form of severe allergic reactions to medication/food/vaccination should not be administered with the vaccine.Individuals with a body temperature over 38.5ºC should postpone vaccination until the fever subsides.

What is the recommended dosage for administration?

According to WHO, the recommendation is two-dose with an interval of 3-4 weeks between first and second dose.

How safe is Sinopharm?

SAGE (Strategic Advisory Group of Experts) from WHO has thoroughly assessed the data on quality, safety and efficacy of the vaccine and has recommended its use for people aged 18 and above.

The most commonly reported side effects in this trial were fever and pain at the injection site. Based on the data from clinical trials, the most common side effects recorded were:

headaches
fatigue
injection site reactions

These side effects were mild to moderate, and similar to those of other authorized vaccines against COVID-19.

FAQs: Frequently asked questions about Sinopharm COVID-19 vaccine

How effective is the Sinopharm Vaccine?

After a thorough review by SAGE, WHO assessed the vaccine efficacy for Sinopharm is up to 75 percent.

Is the Sinopharm Vaccine safe and approved by WHO?

On 7 May 7 2021, WHO approved the Sinopharm COVID-19 vaccine for emergency use, allowing the vaccine to be distributed globally. The Sinopharm vaccine is produced by Beijing Bio-Institute of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG).

SAGE has thoroughly assessed the data on quality, safety and efficacy of the vaccine and has recommended its use for people aged 18 and above.

Due to the small number of participants above 60 years of age, there is limited data on the safety of the vaccines for this age group. While there are no salient differences in the safety profile of the vaccine in older adults compared to the younger age groups, persons aged 60 and above that are considering Sinopharm should seek medical advice and be actively monitored.

What happens to my admission if I do not have the money to pay the deposit?

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts. Separated they live in Bookmar ksgrove right at the coast of the Semantics, a large language ocean. A small river named Duden flows. A wonderful serenity has taken possession of my entire soul, like these sweet mornings of spring which I enjoy with my whole heart. I am alone, and feel the charm of existence in this spot, which was created for the bliss of souls like mine.

Who is eligible for the Sinopharm vaccine?

WHO recommends the Sinopharm vaccine for people aged 18 years and above. Those who have had COVID-19 in the past are eligible for vaccination post six months after COVID-19 infection. Lactating women are eligible to be administered with the Sinopharm vaccine, and able to continue breastfeeding post-vaccination.

Who is ineligible for the Sinopharm vaccine?

Individuals with a history of anaphylaxis or any form of severe allergic reactions to medication/food/vaccination should not be administered with the vaccine.

Individuals with a body temperature over 38.5ºC should postpone vaccination until the fever subsides.

How does Sinopharm compare to other COVID-19 vaccines already in Singapore?

All the vaccines approved by WHO Emergency Use Listing are highly effective in preventing severe disease and hospitalization due to COVID-19.

How is the Sinopharm Vaccine different from the earlier vaccines from Pfizer and Moderna that has been approved for use under the Singapore's COVID-19 Vaccination Programme?

The COVID-19 Sinopharm vaccine triggers the immune system to produce a response to the inactivated version of the COVID-19 virus. MRNA vaccines work by injecting the COVID-19 genetic code into the body, triggering the production of viral proteins that trains the immune system to defend against the virus.

What are the common side effects after the Sinopharm vaccination?

Based on the data from clinical trials, the common side effects are headaches, fatigue and fever. These reported side effects were mild to moderate, like the other approved COVID-19 vaccines.

When will the Covid-19 Sinopharm vaccines be available?

Under the special access route (SAR), OGL Medical Group has received approval to import the Sinopharm vaccines. You may register your interest, and you will be notified on next steps once the vaccine is available. Do note that registration of interest does not guarantee access to vaccines as it is subjected to availability and prevailing criteria.

How many shots do I need to take in order to be fully vaccinated?

Two doses are required with an interval of 3-4 weeks between first and second dose.

What should I do if I am still unsure?

In case of any clarifications, seek advice from your medical doctor to assess your suitability. You may visit one of our clinics to do so or send in an enquiry.

Register your interest for Sinopharm COVID-19 vaccine

We will send you a confirmation within 24 hours.

I wish to receive updates and health news from OGL Medical Group

Note
Registration for interest is open in response to the announcement on the opening up of access to other COVID-19 vaccines under the Special Access Route.

Registration of interest does not guarantee access to vaccines. This is subject to availability and prevailing criteria, as well as the full payment of SGD 100 (for 2 doses of vaccine).

Payment QR Code

After submitted the registration for interest, registrant can make payment via PayNow by scanning the QR code below, then forward the payment receipt screenshot to us via email (ogl@oglmedical.com) with the subject of “Vaccination Registration Payment” and mentioning full name & contact number.

Please take note that all the payments are non-refundable.